✦ LIBER ✦

An open-label, switchover trial to assess the safety and efficacy of Fabrazyme in patients with Fabry disease treated with Replagal enzyme replacement therapy

✍ Scribed by Richards, Sarah; Laney, Dawn; Pervaiz, M. Ali; Shankar, Suma

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, switchover trial to asses

✍ Richards, Sarah; Laney, Dawn; Pervaiz, Muhammad A.; Shankar, Suma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Safety and Efficacy of Enzyme Replacemen

✍ J. Edmond Wraith; Anna Tylki-Szymanska; Nathalie Guffon; Y. Howard Lien; Michel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

A randomized, open-label study to compar

✍ Mathews Adera; Allison Gladden; Pol Boudes 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A Phase 3, multicenter, open-label, swit

✍ Pastores, Gregory M.; Petakov, Milan; Giraldo, Pilar; Rosenbaum, Hanna; Szer, Je 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 614 KB

An open-label long-term phase III extens

✍ Hiroyoshi Ohta,Hiroshi Oka,Chie Usui,Masayuki Ohkura… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 235 KB

An open-label study assessing the safety

✍ T. Dirschka; K. Reich; R. Bissonnette; J. Maares; T. Brown; T. L. Diepgen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB